Drawtex® wound dressing's capillary, hydroductive and electrostatic actions, made possible by exclusive LevaFiber™ Technology, allow it to remove debris, control excessive wound exudate and draw out bacteria and harmful MMPs, setting the stage for wound healing or closure.
• Draws exudate away from the wound surface
• Removes toxic components such as slough, wound debris and bacteria that compromise wound healing
• Vertical and horizontal exudate dispersion controls and retains wound fluid so that it can be transferred to additional dressing layers if needed
• Available in tracheostomy dressing
Drawtex® may be used for: venous, neuropathic foot and pressure ulcers; burns and dehisced surgical wounds; stoma sites; amputations; difficult-to-heal wounds such as mixed etiology leg ulcers, leprosy-related wounds, necrotizing fasciitis, cavity wounds, chronic wounds with slough, clinically infected wounds, fungating cancer wounds and Buruli ulcers.
Contraindicated for use on wounds with arterial bleeding.
A non-adherent wound contact layer such as UrgoTul™ or UrgoTul™ Ag should be used on burns as well as low-exuding wounds to prevent adherence to the wound bed.
Moderate/Highly Exudating Wounds
Before application, cleanse the wound bed with normal saline solution to flush out any debris, pus or dried blood if necessary. Cut Drawtex® to conform to the wound and wound bed, then apply to the wound.
For burns, superficial and "clean" wounds, always use a non-adherent contact layer or fenestrated interface, such as UrgoTul™ or UrgoTul™ Ag, before applying Drawtex®.
For wounds with particular barriers to wound healing such as heavy exudate, slough, necrotic tissue or eschar, Drawtex® may be applied directly to the wound bed.
To secure in place, use a normal bandage or a moisture vapor permeable adhesive film dressing.
Drawtex® can stay in place for up to two days if covered with a semi-occlusive dressing, but otherwise should be changed daily when the dressing is almost saturated.